Advertisement

Topics

Senseonics to Present at the Raymond James 38th Annual Institutional Investors Conference

18:04 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Senseonics Holdings, Inc. (NYSE-MKT:SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today ann...

Other Sources for this Article

Senseonics Holdings, Inc.
R. Don Elsey, 301-556-1602
Chief Financial Officer
don.elsey@senseonics.com

NEXT ARTICLE

More From BioPortfolio on "Senseonics to Present at the Raymond James 38th Annual Institutional Investors Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...